Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-04-020343
Filing Date
2004-11-24
Accepted
2004-11-24 11:45:08
Documents
1
Period of Report
2004-10-25

Document Format Files

Seq Description Document Type Size
1 v09297_form3beckex.html 3  
1 v09297_form3beckex.xml 3 2088
  Complete submission text file 0001144204-04-020343.txt   4029
Mailing Address SUITE 103-158TH HILLSIDE AVE. VICTORIA A1 00000
Business Address SUITE 103-158TH HILLSIDE AVE. VICTORIA A1 00000 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 0331
SIC: 4822 Telegraph & Other Message Communications

Mailing Address 10 HANKIN ST TEL AVIV L3 000000
Business Address 972-54-300-794
YAFFA BECK (Reporting) CIK: 0001309526 (see all company filings)

Type: 3 | Act: 34 | File No.: 333-61610 | Film No.: 041165811